From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30.
NZSSD has issued recommendations for switching to alternative insulins (file linked below), but please be aware Novomix30 is dispensed in a pre-filled disposable pen, whereas patients will require a Humapen for the Humulin and Humalog configurations as these insulins are dispensed in cartridges.
This may be the ideal time to review the management of your patients prescribed Penmix30, Penmix50, or Mixtard30, as they may be suitable for non-insulin medication that was not available when they first started using insulin.
Consider referring these patients to the diabetes lead nurse in your practice, or contacting the Pinnacle clinical diabetes specialist in your area if you would like further information about this.
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreFunding of continuous glucose monitoring and automated insulin delivery begins on 1 October. The Waikato Regional Diabetes Service will take the lead in supporting whānau with Type 1 diabetes (T1D) with this change. Not all people living with T1D are known to the regional diabetes service. In order to re-engage these whānau with the funded technology, please do a query build of your patients with T1D so they can be informed of the localities of drop in clinics and CGM start education.
The clinical diabetes specialist in primary care provides clinical mentorship and advice to the practice team in supporting patients with diabetes.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.